• Brand NameDIVIRA
• Strength300/200mg
• Dosage typeTablets
• therapeutic areaAnti-virals

INDICATION

It is a two-drug combination of emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated:

In combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17 kg.